Financial reports
10-K
2023 FY
Annual report
29 Mar 24
10-Q
2023 Q3
Quarterly report
20 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
9 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
Current reports
8-K
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
26 Mar 24
8-K
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation
28 Nov 23
8-K
Iridex Reports Third Quarter 2023 Financial Results and Business Update
14 Nov 23
8-K
In the Court of Chancery of the State of Delaware
7 Nov 23
8-K
Other Events
31 Oct 23
8-K
In the Court of Chancery of the State of Delaware
18 Oct 23
8-K
Iridex Reports Second Quarter 2023 Financial Results
10 Aug 23
8-K
Departure of Directors or Certain Officers
15 Jun 23
8-K
Iridex Reports First Quarter 2023 Financial Results
11 May 23
8-K
Iridex Reports Fourth Quarter and Full Year 2022 Financial Results
9 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
28 Jun 23
424B3
Prospectus supplement
27 Jul 21
S-8
Registration of securities for employees
9 Jul 21
S-3
Shelf registration
9 Jul 21
S-8
Registration of securities for employees
4 Sep 19
424B5
Prospectus supplement for primary offering
14 Sep 18
424B5
Prospectus supplement for primary offering
13 Sep 18
S-8
Registration of securities for employees
26 Jul 18
S-8
Registration of securities for employees
25 Jul 17
424B4
Prospectus supplement with pricing info
9 Dec 16
Proxies
DEFA14A
Additional proxy soliciting materials
24 May 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
7 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
30 Apr 21
DEF 14A
Definitive proxy
30 Apr 21
DEFA14A
Additional proxy soliciting materials
27 Apr 20
DEF 14A
Definitive proxy
27 Apr 20
Other
SD
Conflict minerals disclosure
30 May 23
SD
Conflict minerals disclosure
26 May 22
EFFECT
Notice of effectiveness
28 Jul 21
CORRESP
Correspondence with SEC
23 Jul 21
UPLOAD
Letter from SEC
16 Jul 21
SD
Conflict minerals disclosure
1 Jun 21
SD
Conflict minerals disclosure
1 Jun 20
SD
Conflict minerals disclosure
31 May 19
UPLOAD
Letter from SEC
5 Oct 18
CORRESP
Correspondence with SEC
1 Oct 18
Ownership
4
Patrick Mercer
21 Sep 23
4
Scott Shuda
15 Jun 23
4
KEN LUDLUM
15 Jun 23
4
Robert Earle Grove
15 Jun 23
4
BEVERLY A HUSS
15 Jun 23
4
Nandini Devi
15 Jun 23
SC 13D
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE
23 Nov 22
4
David Bruce
31 Oct 22
4
Patrick Mercer
31 Oct 22
4
Patrick Mercer
3 Oct 22